Literature DB >> 10931758

Dosage, deletions and dominance: simple models of the evolution of gene expression.

L D Hurst1, J P Randerson.   

Abstract

Dominance of the wild-type allele over spontaneous null mutations, such as deletions, can be explained in terms of the effects of changes in enzyme dose on the flux of metabolic pathways. If ever increasing levels of enzyme activity have ever decreasing effects on the flux of the biochemical pathway, then halving of dosage will always have a lesser effect on flux than half the effect of complete removal of gene activity. Furthermore, if gene expression rates are high, then halving of dose can have a negligible effect on flux and dominance will be strong. Given that strong dominance appears to be common, this leaves open the issue of why enzyme activity levels are so high that a halving of expression rates is of minimal effect. Why produce so much surplus enzyme? One explanation, suggested by Haldane, is that selection favoured high expression levels as a defence against mutation. We model this scenario formally and show that protection from mutation is an extremely weak force determining expression levels. The selective coefficients are only of the order of the mutation rate. However, if we suppose a linear mapping of flux with fitness and a monotonic cost to increased gene expression, it follows simply that here exists an optimal level of gene expression. By contrast to the mutational model, doubling of gene expression rates when the system is distant from the optimum is associated with extremely high selective coefficients (orders of magnitude higher than the mutation rate). When the cost of gene expression is slight the optimal rate of expression is such that strong dominance will follow. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10931758     DOI: 10.1006/jtbi.2000.2095

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  12 in total

1.  Redundancy, antiredundancy, and the robustness of genomes.

Authors:  David C Krakauer; Joshua B Plotkin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

2.  Evolution of dominance in metabolic pathways.

Authors:  Homayoun C Bagheri; Günter P Wagner
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

3.  Sex linkage, sex-specific selection, and the role of recombination in the evolution of sexually dimorphic gene expression.

Authors:  Tim Connallon; Andrew G Clark
Journal:  Evolution       Date:  2010-11-03       Impact factor: 3.694

4.  Inferences about the distribution of dominance drawn from yeast gene knockout data.

Authors:  Aneil F Agrawal; Michael C Whitlock
Journal:  Genetics       Date:  2010-11-23       Impact factor: 4.562

5.  From ENU mutagenesis to population genetics.

Authors:  N Avrion Mitchison; Bryan Clarke
Journal:  Mamm Genome       Date:  2008-03-26       Impact factor: 2.957

6.  Fitness landscapes: an alternative theory for the dominance of mutation.

Authors:  Federico Manna; Guillaume Martin; Thomas Lenormand
Journal:  Genetics       Date:  2011-09-02       Impact factor: 4.562

7.  Widespread transcriptional autosomal dosage compensation in Drosophila correlates with gene expression level.

Authors:  Ashley A McAnally; Lev Y Yampolsky
Journal:  Genome Biol Evol       Date:  2009-12-23       Impact factor: 3.416

8.  Quantitative evolutionary design of glucose 6-phosphate dehydrogenase expression in human erythrocytes.

Authors:  Armindo Salvador; Michael A Savageau
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

9.  Enzyme isoforms may increase phenotypic robustness.

Authors:  Maurizio Tomaiuolo; Richard Bertram; David Houle
Journal:  Evolution       Date:  2008-08-26       Impact factor: 3.694

10.  The evolution of connectivity in metabolic networks.

Authors:  Thomas Pfeiffer; Orkun S Soyer; Sebastian Bonhoeffer
Journal:  PLoS Biol       Date:  2005-06-28       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.